Certain Shares of Eurocine Vaccines AB (publ) are subject to a Lock-Up Agreement Ending on 17-APR-2023. These Shares will be under lockup for 180 days starting from 19-OCT-2022 to 17-APR-2023.

Details:
The CEO, board and the main owner, Flerie Invest AB, have, with customary exceptions, undertaken not to sell shares for a period of six months from the publication of the Rights Issue (so-called lock-up). The lock-up agreement covers 100 percent of each shareholding before the Rights Issue, as well as subscribed holdings in the Rights Issue. Exemption from lock-up applies to the shares that Flerie Invest AB may subscribe to via Toppgarantin.